Camp4 Therapeutics (CAMP) Amortization of Deferred Charges (2023 - 2026)
Camp4 Therapeutics' (CAMP) quarterly Amortization of Deferred Charges came in at $1000.0 in Q1 2026, down 99.1% year-on-year from $111000.0 in Q1 2025, and up 200.0% quarter-over-quarter from -$1000.0 in Q4 2025.
Camp4 Therapeutics (CAMP) Amortization of Deferred Charges (2023 - 2026) Analysis & Trends
Camp4 Therapeutics has disclosed Amortization of Deferred Charges across 4 years of filings, most recently posting $1000.0 for Q1 2026.
- Amortization of Deferred Charges for Q1 2026 came in at $1000.0, down 99.1% year-over-year; the trailing twelve-month figure through Mar 2026 was -$94000.0 (down 156.29% YoY), and the FY2025 annual result was $16000.0, down 80.72% from the prior year.
- Amortization of Deferred Charges came in at $1000.0 for Q1 2026 at Camp4 Therapeutics, up from -$1000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $111000.0 in Q1 2025 to a low of -$95000.0 in Q2 2025.
- The 4-year median for Amortization of Deferred Charges is $17000.0 (2024), against an average of $13000.0.
- Peak annual rise in Amortization of Deferred Charges reached 311.11% in 2025, while the deepest fall reached 531.82% in 2025.
- Camp4 Therapeutics' Amortization of Deferred Charges stood at $30000.0 in 2023, then slumped by 50.0% to $15000.0 in 2024, then tumbled by 106.67% to -$1000.0 in 2025, then soared by 200.0% to $1000.0 in 2026.
- The last three Amortization of Deferred Charges figures came in at $1000.0 (Q1 2026), -$1000.0 (Q4 2025), and $1000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Camp4 Therapeutics | 245.02 Mn | 245.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,000.00 |
| Mar 31, 2026 | 1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | -95,000.00 |
| Jun 30, 2025 | -95,000.00 |
| Mar 31, 2025 | 111,000.00 |
| Mar 31, 2025 | 111,000.00 |
| Dec 31, 2024 | 15,000.00 |
| Dec 31, 2024 | 15,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 22,000.00 |
| Mar 31, 2024 | 27,000.00 |
| Mar 31, 2024 | 27,000.00 |
| Dec 31, 2023 | 30,000.00 |
| Dec 31, 2023 | 30,000.00 |